-logo.png "RESMED/IDR UNRESTR logo")
ResMed Inc develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, portable oxygen concentrators, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes.
Read More…
Industry, Sector and Symbol
Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone+1-858-7462400
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$2.70 billion
Profitability
Miscellaneous
Employees5,940
Next Earnings DateN/A
OptionableOptionable
RESMED/IDR UNRESTR (ASX:RMD) Frequently Asked Questions
What is RESMED/IDR UNRESTR's stock symbol?
RESMED/IDR UNRESTR trades on the ASX under the ticker symbol "RMD."
How often does RESMED/IDR UNRESTR pay dividends? What is the dividend yield for RESMED/IDR UNRESTR?
RESMED/IDR UNRESTR declared a interim dividend on Monday, October 28th. Shareholders of record on Thursday, December 12th will be given a dividend of 0.04 per share on Thursday, December 12th. This represents a yield of 0.19%. The ex-dividend date is Wednesday, November 6th. This is a boost from RESMED/IDR UNRESTR's previous interim dividend of $0.04. View RESMED/IDR UNRESTR's Dividend History.
Has RESMED/IDR UNRESTR been receiving favorable news coverage?
News articles about RMD stock have been trending positive this week, according to InfoTrie Sentiment. The research firm rates the sentiment of press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. RESMED/IDR UNRESTR earned a news sentiment score of 3.0 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the next few days. View News Stories for RESMED/IDR UNRESTR.
Who are some of RESMED/IDR UNRESTR's key competitors?
Some companies that are related to RESMED/IDR UNRESTR include Envista (NVST), Ansell (ANN), Nanosonics (NAN), Gerresheimer (GXI), Enerplus (ERF), Advanced Medical Solutions Group (AMS), Clover (CLV), CRH Medical (CRH), CRH Medical (CRHM), CRH Medical (CRHM), Bovie Medical (BVX), InfuSystem (INFU), Tristel (TSTL), SDI (SDI) and Milestone Scientific (MLSS).
What other stocks do shareholders of RESMED/IDR UNRESTR own?
Who are RESMED/IDR UNRESTR's key executives?
RESMED/IDR UNRESTR's management team includes the folowing people:
- Mr. Michael J. Farrell BE, SM, MBA, CEO & Director (Age 47)
- Mr. Robert A. Douglas, Pres & COO (Age 59)
- Mr. Brett A. Sandercock, Chief Financial Officer (Age 52)
- Mr. David B. Pendarvis, Chief Admin. Officer, Global Gen. Counsel & Sec. (Age 60)
- Mr. James Hollingshead, Pres of Sleep Bus. (Age 56)
What is RESMED/IDR UNRESTR's stock price today?
One share of RMD stock can currently be purchased for approximately A$23.13.
How big of a company is RESMED/IDR UNRESTR?
What is RESMED/IDR UNRESTR's official website?
How can I contact RESMED/IDR UNRESTR?
RESMED/IDR UNRESTR's mailing address is 9001 Spectrum Center Blvd, SAN DIEGO, CA 92123-1438, United States. The company can be reached via phone at +1-858-7462400.
MarketBeat Community Rating for RESMED/IDR UNRESTR (ASX RMD)
MarketBeat's community ratings are surveys of what our community members think about RESMED/IDR UNRESTR and other stocks. Vote "Outperform" if you believe RMD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RMD will underperform the S&P 500 over the long term. You may vote once every thirty days.
